STOCK TITAN

Point72 group reports 5.3% Evommune (EVMN) stake of 1.91M shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc. and Steven A. Cohen report beneficial ownership of 1,910,489 shares of Evommune, Inc. common stock, representing 5.3% of the class as of July 15, 2026. The shares, held by Point72 Associates, carry shared voting and dispositive power only.

The reporting persons state that this statement should not be construed as an admission that they are beneficial owners of these shares for purposes of Section 13 of the Exchange Act.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 1,910,489 shares Beneficial ownership reported for each reporting person as of close of business on July 15, 2026
Percent of class 5.3% Reported percentage of Evommune common stock outstanding represented by the beneficially owned shares
Sole voting power 0 shares Number of Evommune shares over which each reporting person has sole power to vote
Shared voting power 1,910,489 shares Number of Evommune shares over which each reporting person has shared power to vote
Sole dispositive power 0 shares Number of Evommune shares over which each reporting person has sole power to dispose
Shared dispositive power 1,910,489 shares Number of Evommune shares over which each reporting person has shared power to dispose
Ownership date July 15, 2026 Date as of which the ownership information and powers are reported
beneficial owner regulatory
"should not be construed as an admission that any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power financial
"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 1,910,489.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
investment management agreement financial
"Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
Joint Filing Agreement regulatory
"have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1"
Rule 13d-1(k) regulatory
"they have agreed to file this jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Evommune (EVMN) does the Point72 group report owning?

The Point72 group reports beneficial ownership of 5.3% of Evommune (EVMN) common stock, equal to 1,910,489 shares as of the close of business on July 15, 2026.

Who are the reporting persons in this Schedule 13G for Evommune (EVMN)?

The reporting persons are Point72 Asset Management, L.P., Point72 Capital Advisors, Inc. and Steven A. Cohen, each reporting on Evommune (EVMN) shares held by Point72 Associates, LLC under their investment and control relationships.

Do the Point72 reporting persons have sole or shared voting power over Evommune (EVMN) shares?

The reporting persons have 0 shares with sole voting power and 1,910,489 shares with shared voting power in Evommune (EVMN), matching their shared dispositive power position as of July 15, 2026.

Which entity is entitled to dividends or sale proceeds from the Evommune (EVMN) shares?

Point72 Associates, LLC has the right to receive or direct the receipt of dividends and sale proceeds from more than 5 percent of the outstanding Evommune (EVMN) common shares reported in this filing.

What do the reporting persons say about their beneficial ownership status of Evommune (EVMN) shares?

They state that this statement should not be construed as an admission that any reporting person is the beneficial owner of the Evommune (EVMN) shares for purposes of Section 13 of the Exchange Act.





30054Y107

(CUSIP Number)
07/15/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/16/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/16/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/16/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement